These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 6895841)
1. Morphogenesis of colonic carcinoma. Ultrastructural studies of azoxymethane-induced early lesions in colon epithelium of Fischer 344 rats. Shamsuddin AM Arch Pathol Lab Med; 1982 Mar; 106(3):140-4. PubMed ID: 6895841 [TBL] [Abstract][Full Text] [Related]
2. Effects of carcinogen dosage on experimental colonic carcinogenesis by azoxymethane: an ultrastructural study of grossly normal colonic mucosa. Pan Q; Hamilton SR; Hyland J; Boitnott JK J Natl Cancer Inst; 1985 Mar; 74(3):689-98. PubMed ID: 3856071 [TBL] [Abstract][Full Text] [Related]
3. Colon epithelium. II. In vivo studies of colon carcinogenesis. Light microscopic, histochemical, and ultrastructural studies of histogenesis of azoxymethane-induced colon carcinomas in Fischer 344 rats. Shamsuddin AK; Trump BF J Natl Cancer Inst; 1981 Feb; 66(2):389-401. PubMed ID: 6935486 [No Abstract] [Full Text] [Related]
4. Scanning electron microscopy of colonic lesions in 1,2-dimethylhydrazine-treated rats. Paulsen JE; Namork E; Alexander J Anticancer Res; 2005; 25(6B):3883-8. PubMed ID: 16309175 [TBL] [Abstract][Full Text] [Related]
5. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane. Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579 [TBL] [Abstract][Full Text] [Related]
6. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031 [TBL] [Abstract][Full Text] [Related]
7. Kinetic changes in mucosal ornithine decarboxylase activity during azoxymethane-induced colonic carcinogenesis in the rat. Luk GD; Hamilton SR; Yang P; Smith JA; O'Ceallaigh D; McAvinchey D; Hyland J Cancer Res; 1986 Sep; 46(9):4449-52. PubMed ID: 3731101 [TBL] [Abstract][Full Text] [Related]
8. Three-dimensional analysis of isolated hexosaminidase-altered aberrant crypts from colons of 1,2-dimethylhydrazine-treated rats. Tsukamoto T; Sakai H; Hirata A; Fukami H; Tatematsu M Exp Toxicol Pathol; 2006 Mar; 57(4):283-9. PubMed ID: 16414254 [TBL] [Abstract][Full Text] [Related]
9. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Raju J; Patlolla JM; Swamy MV; Rao CV Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963 [TBL] [Abstract][Full Text] [Related]
10. Colon epithelium. III. In vitro studies of colon carcinogenesis in Fischer 344 rats. N-methyl-N'-nitro-N-nitrosoguanidine-induced changes in colon epithelium in explant culture. Shamsuddin AK; Trump BF J Natl Cancer Inst; 1981 Feb; 66(2):403-11. PubMed ID: 6935487 [TBL] [Abstract][Full Text] [Related]
11. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Rao CV; Hirose Y; Indranie C; Reddy BS Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748 [TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057 [TBL] [Abstract][Full Text] [Related]
13. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat. Paulsen JE; Løberg EM; Olstørn HB; Knutsen H; Steffensen IL; Alexander J Cancer Res; 2005 Jan; 65(1):121-9. PubMed ID: 15665287 [TBL] [Abstract][Full Text] [Related]
14. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis. Femia AP; Dolara P; Caderni G Carcinogenesis; 2004 Feb; 25(2):277-81. PubMed ID: 14604897 [TBL] [Abstract][Full Text] [Related]
15. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322 [TBL] [Abstract][Full Text] [Related]
16. Fasting/refeeding enhances the crypt multiplicity in rat colon carcinogenesis induced by azoxymethane. Premoselli F; Sesca E; Chiara M; Binasco V; Tessitore L Boll Soc Ital Biol Sper; 1996; 72(9-10):239-45. PubMed ID: 9425720 [TBL] [Abstract][Full Text] [Related]
17. Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Yamada Y; Yoshimi N; Hirose Y; Matsunaga K; Katayama M; Sakata K; Shimizu M; Kuno T; Mori H Cancer Res; 2001 Mar; 61(5):1874-8. PubMed ID: 11280741 [TBL] [Abstract][Full Text] [Related]
18. Prevalent location of flat dysplastic aberrant crypt foci near lymphoid follicles in the colon of azoxymethane-treated rats. Paulsen JE; Steffensen IL; Olstørn HB; Alexander J Anticancer Res; 2006; 26(3A):1803-7. PubMed ID: 16827110 [TBL] [Abstract][Full Text] [Related]
19. Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. Caderni G; Femia AP; Giannini A; Favuzza A; Luceri C; Salvadori M; Dolara P Cancer Res; 2003 May; 63(10):2388-92. PubMed ID: 12750256 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]